Centessa Pharmaceuticals plc - Ordinary Shares, nominal value 0.002 per share (CNTA)

CUSIP: 152309100

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+15,436,787
Put/Call ratio
60%
SEC-reported price per share
$25.01
Number of holders
148
Value change
+$388,868,676
Number of buys
87
Open additional details 1 more signal available
Number of sells
64
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
153,608,082

Security key

152309100

Report period

Q4 2025

Institutions

148

Top holders

10

Ownership snapshot

Top reported holders of CNTA - Centessa Pharmaceuticals plc - Ordinary Shares, nominal value 0.002 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
General Atlantic Cooperat...
Disclosed value leader
Medicxi Ventures Manageme...
Comparable rows
15/15
Latest evidence
25 Nov 2025
13D/G 13F Lead comparable stake: 5% 13D/G row: General Atlantic Cooperatief U.A. Showing 1-6 of 15 holder rows.

Quick read

General Atlantic Cooperatief U.A. leads the comparable SEC ownership view at 5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens General Atlantic Cooperatief U.A.'s linked filing trail.
Comparable ownership Top 5
General Atlantic Cooperatief U.A. 5%
Medicxi Ventures Management (Jers... 13%
Avoro Capital Advisors LLC 7%
ADAGE CAPITAL PARTNERS GP, L.L.C. 6.5%
Index Venture Life Associates VI Ltd 6.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
General Atlantic Cooperatief U.A.
13D/G
5%
$180,192,368
7,366,818 shares
-$56,624,900 25 Nov 2025
Medicxi Ventures Management (Jersey) Ltd
13F
Company
13F
13%
$484,106,557
19,963,157 shares
30 Sep 2025
Avoro Capital Advisors LLC
13F
Company
13F
7%
$262,095,940
10,808,080 shares
30 Sep 2025
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
6.5%
$243,348,750
10,035,000 shares
30 Sep 2025
Index Venture Life Associates VI Ltd
13F
Company
13F
6.5%
$241,573,383
9,961,789 shares
30 Sep 2025
GENERAL ATLANTIC, L.P.
13F
Company
13F
6.3%
$234,784,087
9,681,818 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
148
Shares
143,761,479
Rows available
148
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
124
Q4 2025 holders
148
Holder diff
24
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .